4.7 Review

Passive Immunization in Alpha-Synuclein Preclinical Animal Models

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut

Jacqui T. Nimmo et al.

Summary: Immunotherapy with the UB-312 vaccine was effective in preventing functional deficits and central and peripheral pathology in Thy1SNCA/15 mice, showing reduced levels of alpha Syn oligomers in the brain regions and a significant reduction in alpha Syn load in the colon.

ACTA NEUROPATHOLOGICA (2022)

Article Neurosciences

Animal models of brain-first and body-first Parkinson's disease

Nathalie Van Den Berge et al.

Summary: Alpha-synuclein aggregates are the hallmark of Parkinson's disease and can propagate along the brain-body axis in a stereotypical pattern. The heterogeneity of symptoms and pathology in Parkinson's disease patients may be explained by the variable onset site, either in the brain or body. Animal models have been developed to reproduce Parkinson's disease pathology in order to study the site of disease onset.

NEUROBIOLOGY OF DISEASE (2022)

Article Neurosciences

Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies

Sheila M. Fleming et al.

Summary: Parkinson's disease is characterized by the abnormal accumulation of alpha-synuclein in the brain and the loss of dopaminergic neurons. Immunotherapies targeting alpha-synuclein have become a key focus for the development of novel therapies for PD.

NEUROPHARMACOLOGY (2022)

Article Gastroenterology & Hepatology

Inflammatory bowel disease and Parkinson's disease: common pathophysiological links

Ho-Su Lee et al.

Summary: Inflammatory bowel disease and Parkinson's disease have been shown to have a bidirectional link, with shared genetic loci such as LRRK2. Recent studies suggest that inflammatory bowel disease may increase the risk of developing Parkinson's disease. The underlying mechanisms of gut-brain interactions are still not fully understood, but recent findings are beginning to shed light on this connection.
Article Neurosciences

ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease

Eva Nordstrom et al.

Summary: ABBV-0805 is a humanized monoclonal antibody with high selectivity for aggregated alpha-synuclein, demonstrating efficacy in cellular and animal models, and showing potential disease-modifying treatment for Parkinson's disease based on strong preclinical findings.

NEUROBIOLOGY OF DISEASE (2021)

Article Neurosciences

Neuropathological evidence of body-first vs. brain-first Lewy body disease

Per Borghammer et al.

Summary: The aggregation of alpha-synuclein into inclusion bodies, known as Lewy pathology, is a key feature of Parkinson's disease and Dementia with Lewy bodies. Post mortem studies have shown that Lewy pathology follows two main distribution patterns in the brain, with some patients having pathogenic alpha-synuclein originating in the enteric nervous system and others originating inside the central nervous system.

NEUROBIOLOGY OF DISEASE (2021)

Review Neurosciences

The alpha-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline

Per Borghammer

Summary: The new model of Parkinson's disease pathogenesis, the SOC model, distinguishes between brain-first and body-first subtypes based on the location of initial alpha-synuclein pathology. Brain-first cases show unilateral pathology, leading to asymmetric dopaminergic degeneration and motor asymmetry, while body-first cases display more symmetric pathology and less motor asymmetry.

JOURNAL OF PARKINSONS DISEASE (2021)

Review Medicine, General & Internal

Gastrointestinal Dysfunction in Parkinson's Disease

Casper Skjaerbaek et al.

Summary: Parkinson's disease is the second most common neurodegenerative disease characterized by pathological alpha-synuclein deposits in both the brain and the entire digestive tract. Gastrointestinal symptoms such as dysphagia, bloating, and constipation are common in PD patients. The accumulation of gastrointestinal pathology may begin years before a clinical diagnosis of PD, with constipation shown to increase the risk of PD and truncal vagotomy potentially decreasing the risk.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Neurosciences

Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain

Nelson Ferreira et al.

Summary: This study revealed that inoculation of mouse alpha-synuclein pre-formed fibrils can induce retrograde trans-synaptic spreading of alpha-Syn pathology across sensory neurons and dorsal nerve roots in a transgenic mouse model of PD, leading to impaired nociceptive response, reduced nerve conduction velocities, and fiber degeneration. This suggests a link between the transneuronal propagation of alpha-Syn pathology with sensory neuron dysfunction and neuropathic impairment, providing promising avenues for investigating mechanisms underlying pain in PD.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Clinical Neurology

Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats

Nathalie Van den Berge et al.

Summary: Using a rat model, it was found that the propagation of alpha-synuclein pathology from the gut to the brain is more efficient in old rats, resulting in dysfunction of the heart and stomach similar to observations in patients with Parkinson's disease. Age was shown to be a crucial factor for the aggregation and propagation of alpha-synuclein, highlighting the importance of using aged animals in preclinical studies for better understanding of age-dependent interactions.
Review Biochemistry & Molecular Biology

The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses

Asad Jan et al.

Summary: The pathological aggregation of presynaptic protein alpha-synuclein and its propagation through synaptically coupled neuroanatomical tracts are believed to underlie the progression of Parkinson's disease and other synucleinopathies. Understanding the mechanisms of alpha-synuclein propagation may provide insights into the etiology of PD and identify new therapeutic targets.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Neurosciences

Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy

Joachim Brumberg et al.

Summary: Pathological aggregates of alpha-synuclein can be detected in peripheral dermal nerve fibers of patients with idiopathic Parkinson's disease and multiple system atrophy, indicating overlapping pathophysiological mechanisms between the two diseases and suggesting that alpha-synuclein may contribute to cardiac sympathetic neurons impairment in patients with synucleinopathies.

NEUROBIOLOGY OF DISEASE (2021)

Article Clinical Neurology

Cerebrospinal fluid and plasma distribution of anti-α-synuclein IgMs and IgGs in multiple system atrophy and Parkinson's disease

Jonas Folke et al.

Summary: The study revealed a reduction in high-affinity/avidity anti-alpha-syn IgG nAbs in CSF samples from MSA and PD patients, along with varied levels of anti-alpha-syn IgM nAbs in CSF and plasma from both patient groups. Additionally, disease-specific profiles of anti-alpha-syn IgG subclasses were observed in the CSF, with MSA patients showing increased IgG1, IgG2, and IgG3 levels, while PD patients exhibited increased IgG2 and reduced IgG4 levels.

PARKINSONISM & RELATED DISORDERS (2021)

Article Neurosciences

Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson's Disease Subtypes

Karoline Knudsen et al.

Summary: The analysis of PET and SPECT data revealed that patients with RBD have more symmetric nigrostriatal degeneration. This supports the hypothesis of body-first PD, characterized by more symmetric propagation of pathogenic alpha-synuclein.

JOURNAL OF PARKINSONS DISEASE (2021)

Article Genetics & Heredity

Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein

Yun-Hsiang Chen et al.

Summary: The study demonstrates that intervention with AAV-NAC32 on alpha-Synuclein in animals can improve PD-like symptoms, including reducing bradykinesia and restoring tyrosine hydroxylase loss. This research provides hope for this intervention technique as a potential therapeutic candidate for PD.
Article Geriatrics & Gerontology

Orthostatic Hypotension in Parkinson Disease

Jose-Alberto Palma et al.

CLINICS IN GERIATRIC MEDICINE (2020)

Article Clinical Neurology

Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease

Shunsuke Koga et al.

BRAIN PATHOLOGY (2020)

Article Clinical Neurology

Autonomic dysfunction and phenoconversion in idiopathic REM sleep behavior disorder

Stuart J. McCarter et al.

CLINICAL AUTONOMIC RESEARCH (2020)

Review Pharmacology & Pharmacy

Immunization therapies for Parkinson's disease: state of the art and considerations for future clinical trials

Angelo Antonini et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)

Article Multidisciplinary Sciences

α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease

Cecilia S. Lindestam Arlehamn et al.

NATURE COMMUNICATIONS (2020)

Editorial Material Clinical Neurology

Dementia with Lewy bodies and Parkinson disease dementia: More different than similar?

Melissa J. Armstrong et al.

NEUROLOGY (2020)

Article Clinical Neurology

Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder - A PET study

Katrine B. Andersen et al.

PARKINSONISM & RELATED DISORDERS (2020)

Article Endocrinology & Metabolism

Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development

Siddhartha S. Ghosh et al.

JOURNAL OF THE ENDOCRINE SOCIETY (2020)

Review Clinical Neurology

Is Braak staging valid for all types of Parkinson's disease?

Kurt A. Jellinger

JOURNAL OF NEURAL TRANSMISSION (2019)

Review Clinical Neurology

Autonomic Dysfunction in α-Synucleinopathies

Jose Javier Mendoza-Velasquez et al.

FRONTIERS IN NEUROLOGY (2019)

Review Neurosciences

The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge

Sven C. D. van IJzendoorn et al.

JOURNAL OF PARKINSONS DISEASE (2019)

Review Neurosciences

Brain-First versus Gut-First Parkinson's Disease: A Hypothesis

Per Borghammer et al.

JOURNAL OF PARKINSONS DISEASE (2019)

Review Neurosciences

Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review

Jeffrey M. Boertien et al.

JOURNAL OF PARKINSONS DISEASE (2019)

Review Neurosciences

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

Naomi P. Visanji et al.

TRANSLATIONAL NEURODEGENERATION (2019)

Review Neurosciences

Inflammatory Bowel Diseases and Parkinson's Disease

Tomasz Brudek

JOURNAL OF PARKINSONS DISEASE (2019)

Review Clinical Neurology

Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease

Han-Lin Chiang et al.

JOURNAL OF MOVEMENT DISORDERS (2019)

Review Clinical Neurology

Alpha-Synudein in Skin Nerve Fibers as a Biomarker for Alpha-Synudeinopathies

Jee Young Kim et al.

JOURNAL OF CLINICAL NEUROLOGY (2019)

Review Clinical Neurology

Idiopathic REM sleep behaviour disorder and neurodegeneration - an update

Birgit Hoegl et al.

NATURE REVIEWS NEUROLOGY (2018)

Review Neurosciences

Diagnosis of multiple system atrophy

Jose-Alberto Palma et al.

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2018)

Article Multidisciplinary Sciences

Structural characteristics and membrane interactions of tandem α-synuclein oligomers

Chunhua Dong et al.

SCIENTIFIC REPORTS (2018)

Article Clinical Neurology

Skin Nerve Phosphorylated alpha-Synuclein Deposits in Parkinson Disease With Orthostatic Hypotension

Vincenzo Donadio et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)

Review Clinical Neurology

A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease

Kirsten M. Scott et al.

FRONTIERS IN NEUROLOGY (2018)

Article Clinical Neurology

Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type

J. Brettschneider et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2017)

Article Multidisciplinary Sciences

T cells from patients with Parkinson's disease recognize α-synuclein peptides

David Sulzer et al.

NATURE (2017)

Article Neurosciences

α-Synuclein promotes dilation of the exocytotic fusion pore

Todd Logan et al.

NATURE NEUROSCIENCE (2017)

Article Clinical Neurology

REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease

Laurene Leclair-Visonneau et al.

NEUROLOGY (2017)

Article Clinical Neurology

RNA Interference of Human α-Synuclein in Mouse

Young-Cho Kim et al.

Frontiers in Neurology (2017)

Review Clinical Neurology

Alpha-synuclein oligomers: a new hope

Nora Bengoa-Vergniory et al.

ACTA NEUROPATHOLOGICA (2017)

Review Clinical Neurology

Development of Passive Immunotherapies for Synucleinopathies

Ann-Louise Bergstrom et al.

MOVEMENT DISORDERS (2016)

Article Clinical Neurology

Pathological α-Synuclein in Gastrointestinal Tissues from Prodromal Parkinson Disease Patients

Morten Gersel Stokholm et al.

ANNALS OF NEUROLOGY (2016)

Review Clinical Neurology

Pure Autonomic Failure

Pariwat Thaisetthawatkul

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)

Review Clinical Neurology

Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies

Maria Xilouri et al.

MOVEMENT DISORDERS (2016)

Article Chemistry, Physical

Conformational ensemble of human α-synuclein physiological form predicted by molecular simulations

G. Rossetti et al.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2016)

Review Biochemistry & Molecular Biology

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine

Gabor G. Kovacs

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Clinical Neurology

Vagotomy and Subsequent Risk of Parkinson's Disease

Elisabeth Svensson et al.

ANNALS OF NEUROLOGY (2015)

Article Clinical Neurology

Expanding the spectrum of neuronal pathology in multiple system atrophy

Matthew D. Cykowski et al.

Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Article Medicine, Research & Experimental

Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference

Masaki Takahashi et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2015)

Article Neurosciences

Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis

Karina J. Vargas et al.

JOURNAL OF NEUROSCIENCE (2014)

Article Neurosciences

α-Synuclein mutations cluster around a putative protein loop

Eleanna Kara et al.

NEUROSCIENCE LETTERS (2013)

Article Biochemistry & Molecular Biology

N-terminal acetylation is critical for forming a-helical oligomer of a-synuclein

Adam J. Trexler et al.

PROTEIN SCIENCE (2012)

Article Medicine, Research & Experimental

α-Synuclein in Parkinson's Disease

Leonidas Stefanis

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Article Multidisciplinary Sciences

A soluble α-synuclein construct forms a dynamic tetramer

Wei Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Clinical Neurology

Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update

Kurt A. Jellinger et al.

ACTA NEUROPATHOLOGICA (2010)

Article Clinical Neurology

Are synucleinopathies prion-like disorders?

Elodie Angot et al.

LANCET NEUROLOGY (2010)

Article Biotechnology & Applied Microbiology

In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration

Oleg S. Gorbatyuk et al.

MOLECULAR THERAPY (2010)

Review Biochemistry & Molecular Biology

A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders

Kurt A. Jellinger

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)

Article Clinical Neurology

Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?

Hiroshige Fujishiro et al.

ACTA NEUROPATHOLOGICA (2008)

Article Clinical Neurology

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease

Dennis W. Dickson et al.

ACTA NEUROPATHOLOGICA (2008)

Article Clinical Neurology

Second consensus statement on the diagnosis of multiple system atrophy

S. Gilman et al.

NEUROLOGY (2008)

Article Clinical Neurology

Nonmotor symptoms of Parkinson's disease: Prevalence and awareness of patients and families

Sang-Myung Cheon et al.

PARKINSONISM & RELATED DISORDERS (2008)

Review Clinical Neurology

Parkinson's disease: a dual-hit hypothesis

C. H. Hawkes et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)

Article Neurosciences

Different species of α-synuclein oligomers induce calcium influx and seeding

Karin M. Danzer et al.

JOURNAL OF NEUROSCIENCE (2007)

Article Clinical Neurology

Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology

Yoshio Tsuboi et al.

PARKINSONISM & RELATED DISORDERS (2007)

Article Clinical Neurology

Sweating dysfunctions in Parkinson's disease

Masaaki Hirayama

JOURNAL OF NEUROLOGY (2006)

Article Medicine, General & Internal

α-synuclein locus duplication as a cause of familial Parkinson's disease

MC Chartier-Harlin et al.

LANCET (2004)

Review Cell Biology

Stages in the development of Parkinson's disease-related pathology

H Braak et al.

CELL AND TISSUE RESEARCH (2004)

Article Multidisciplinary Sciences

α-synuclein locus triplication causes Parkinson's disease

AB Singleton et al.

SCIENCE (2003)

Review Geriatrics & Gerontology

Staging of brain pathology related to sporadic Parkinson's disease

H Braak et al.

NEUROBIOLOGY OF AGING (2003)

Article Biochemistry & Molecular Biology

A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly

BI Giasson et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Clinical Neurology

Immunohistochemical and biochemical studies demonstrate a distinct profile of α-synuclein permutations in multiple system atrophy

JE Duda et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)